Christopher Patusky, Director at UNITED THERAPEUTICS Corp (UTHR), sold 8,991 shares at $362.95 ($3.3M) on 2025-01-10, disclosed to the SEC on 2025-01-13.
Scheduled sale ($3.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $358.65 | 300 | $108K | 3.3% |
| 2 | $359.82 | 600 | $216K | 6.6% |
| 3 | $361.04 | 969 | $350K | 10.8% |
| 4 | $361.04 | 969 | $350K | 10.8% |
| 5 | $362.03 | 1,930 | $699K | 21.5% |
| 6 | $362.03 | 1,930 |
| $699K |
| 21.5% |
| 7 | $362.95 | 1,092 | $396K | 12.2% |
| 8 | $362.95 | 1,092 | $396K | 12.2% |
| 9 | $363.86 | 109 | $40K | 1.2% |
| Total | $361.80 avg | 8,991 | $3.3M | 100% |
| Filing → |
| UTHR | SELL | 2025-12-16 | $496K | — | Filing → |
| UTHR | SELL | 2025-03-20 | $3.0M | — | Filing → |
| UTHR | SELL | 2024-09-05 | $1.8M | — | Filing → |